Authors
Loading...
Does not warrant changes in RAAS-targeted therapy; leaves open ACE-independent mechanisms in genetic hypertension models.
Key points are not available for this paper at this time.
Higashino et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: